{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1363388845710146816.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.1007/s00401-006-0063-y"}},{"identifier":{"@type":"URI","@value":"http://link.springer.com/content/pdf/10.1007/s00401-006-0063-y.pdf"}},{"identifier":{"@type":"URI","@value":"http://link.springer.com/article/10.1007/s00401-006-0063-y/fulltext.html"}},{"identifier":{"@type":"URI","@value":"http://link.springer.com/content/pdf/10.1007/s00401-006-0063-y"}},{"identifier":{"@type":"PMID","@value":"16596424"}}],"dc:title":[{"@value":"Increased expression of podoplanin in malignant astrocytic tumors as a novel molecular marker of malignant progression"}],"description":[{"notation":[{"@value":"Podoplanin (aggrus) is a mucin-like transmembrane sialoglycoprotein that is expressed on lymphatic endothelial cells. Podoplanin is putatively involved in cancer cell migration, invasion, metastasis, and malignant progression and may be involved in platelet aggregation. Previously, we showed upregulated expression of podoplanin in central nervous system (CNS) germinomas, but not in non-germinomatous germ cell tumors, except for parts of immature teratomas in limited numbers. However, little information exists about its role in CNS astrocytic tumors. In this study, 188 astrocytic tumors (30 diffuse astrocytomas, 43 anaplastic astrocytomas, and 115 glioblastomas) were investigated using immunohistochemistry with an anti-podoplanin antibody, YM-1. In 11 of 43 anaplastic astrocytomas (25.6%) and in 54 of 115 glioblastomas (47.0%), podoplanin was expressed on the surface of anaplastic astrocytoma cells and glioblastoma cells, especially around necrotic areas and proliferating endothelial cells. However, the surrounding brain parenchyma was not stained by YM-1. On the other hand, podoplanin expression was not observed in diffuse astrocytoma (0/30: 0%). Furthermore, we investigated the expression of podoplanin using quantitative real-time PCR and Western blot analysis in 54 frozen astrocytic tumors (6 diffuse astrocytomas, 14 anaplastic astrocytomas, and 34 glioblastomas). Podoplanin mRNA and protein expression were markedly higher in glioblastomas than in anaplastic astrocytomas. These data suggest that podoplanin expression might be associated with malignancy of astrocytic tumors."}]}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1383388845710146817","@type":"Researcher","foaf:name":[{"@value":"Kazuhiko Mishima"}]},{"@id":"https://cir.nii.ac.jp/crid/1383388845710146816","@type":"Researcher","foaf:name":[{"@value":"Yukinari Kato"}]},{"@id":"https://cir.nii.ac.jp/crid/1383388845710146820","@type":"Researcher","foaf:name":[{"@value":"Mika Kato Kaneko"}]},{"@id":"https://cir.nii.ac.jp/crid/1383388845710146818","@type":"Researcher","foaf:name":[{"@value":"Ryo Nishikawa"}]},{"@id":"https://cir.nii.ac.jp/crid/1383388845710146819","@type":"Researcher","foaf:name":[{"@value":"Takanori Hirose"}]},{"@id":"https://cir.nii.ac.jp/crid/1383388845710146688","@type":"Researcher","foaf:name":[{"@value":"Masao Matsutani"}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"00016322"},{"@type":"EISSN","@value":"14320533"},{"@type":"PISSN","@value":"https://id.crossref.org/issn/00016322"}],"prism:publicationName":[{"@value":"Acta Neuropathologica"}],"dc:publisher":[{"@value":"Springer Science and Business Media LLC"}],"prism:publicationDate":"2006-04-05","prism:volume":"111","prism:number":"5","prism:startingPage":"483","prism:endingPage":"488"},"reviewed":"false","dc:rights":["http://www.springer.com/tdm"],"url":[{"@id":"http://link.springer.com/content/pdf/10.1007/s00401-006-0063-y.pdf"},{"@id":"http://link.springer.com/article/10.1007/s00401-006-0063-y/fulltext.html"},{"@id":"http://link.springer.com/content/pdf/10.1007/s00401-006-0063-y"}],"createdAt":"2006-04-04","modifiedAt":"2021-07-25","foaf:topic":[{"@id":"https://cir.nii.ac.jp/all?q=Membrane%20Glycoproteins","dc:title":"Membrane Glycoproteins"},{"@id":"https://cir.nii.ac.jp/all?q=Blotting,%20Western","dc:title":"Blotting, Western"},{"@id":"https://cir.nii.ac.jp/all?q=Astrocytoma","dc:title":"Astrocytoma"},{"@id":"https://cir.nii.ac.jp/all?q=Immunohistochemistry","dc:title":"Immunohistochemistry"},{"@id":"https://cir.nii.ac.jp/all?q=Central%20Nervous%20System%20Neoplasms","dc:title":"Central Nervous System Neoplasms"},{"@id":"https://cir.nii.ac.jp/all?q=Gene%20Expression%20Regulation,%20Neoplastic","dc:title":"Gene Expression Regulation, Neoplastic"},{"@id":"https://cir.nii.ac.jp/all?q=Biomarkers,%20Tumor","dc:title":"Biomarkers, Tumor"},{"@id":"https://cir.nii.ac.jp/all?q=Disease%20Progression","dc:title":"Disease Progression"},{"@id":"https://cir.nii.ac.jp/all?q=Humans","dc:title":"Humans"},{"@id":"https://cir.nii.ac.jp/all?q=RNA,%20Messenger","dc:title":"RNA, Messenger"},{"@id":"https://cir.nii.ac.jp/all?q=Glioblastoma","dc:title":"Glioblastoma"}],"relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1050022708920017024","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"The chimeric antibody chLpMab-7 targeting human podoplanin suppresses pulmonary metastasis via ADCC and CDC rather than via its neutralizing activity"}]},{"@id":"https://cir.nii.ac.jp/crid/1050585658873871104","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Antitumor activity of chLpMab‐2, a human–mouse chimeric cancer‐specific antihuman podoplanin antibody, via antibody‐dependent cellular cytotoxicity"},{"@value":"Antitumor activity of chLpMab-2, a human-mouse chimeric cancer-specific antihuman podoplanin antibody, via antibody-dependent cellular cytotoxicity"}]},{"@id":"https://cir.nii.ac.jp/crid/1360002214455148160","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Development and characterization of anti‐glycopeptide monoclonal antibodies against human podoplanin, using glycan‐deficient cell lines generated by <scp>CRISPR</scp>/Cas9 and <scp>TALEN</scp>"}]},{"@id":"https://cir.nii.ac.jp/crid/1360002216179578240","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Podoplanin expression in advanced atherosclerotic lesions of human aortas"}]},{"@id":"https://cir.nii.ac.jp/crid/1360002216855641600","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"A Cancer-specific Monoclonal Antibody Recognizes the Aberrantly Glycosylated Podoplanin"}]},{"@id":"https://cir.nii.ac.jp/crid/1360002217481970432","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Anti-podoplanin Monoclonal Antibody LpMab-7 Detects Metastatic Lesions of Osteosarcoma"}]},{"@id":"https://cir.nii.ac.jp/crid/1360002218344096512","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"C‐type lectin‐like receptor 2 promotes hematogenous tumor metastasis and prothrombotic state in tumor‐bearing mice"}]},{"@id":"https://cir.nii.ac.jp/crid/1360004234481651200","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Monoclonal Antibody LpMab-9 Recognizes\n                    <i>O</i>\n                    -glycosylated N-Terminus of Human Podoplanin"}]},{"@id":"https://cir.nii.ac.jp/crid/1360004235553112192","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Immunohistochemical analysis‐based proteomic subclassification of newly diagnosed glioblastomas"}]},{"@id":"https://cir.nii.ac.jp/crid/1360004239690530816","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Podoplanin-mediated TGF-β-induced epithelial-mesenchymal transition and its correlation with bHLH transcription factor DEC in TE-11 cells"}]},{"@id":"https://cir.nii.ac.jp/crid/1360009142848398080","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Crystal structure of an anti-podoplanin antibody bound to a disialylated O-linked glycopeptide"}]},{"@id":"https://cir.nii.ac.jp/crid/1360009142867615104","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Podoplanin as an Attractive Target of CAR T Cell Therapy"}]},{"@id":"https://cir.nii.ac.jp/crid/1360009142920875264","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Development of Core-Fucose-Deficient Humanized and Chimeric Anti-Human Podoplanin Antibodies"}]},{"@id":"https://cir.nii.ac.jp/crid/1360013168805748352","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Development of Monoclonal Antibody PMab-269 Against California Sea Lion Podoplanin"}]},{"@id":"https://cir.nii.ac.jp/crid/1360013171835846656","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Preclinical Evaluation of Podoplanin-Targeted Alpha-Radioimmunotherapy with The Novel Antibody NZ-16 for Malignant Mesothelioma"}]},{"@id":"https://cir.nii.ac.jp/crid/1360283690345605248","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Platelet-activating factor podoplanin: from discovery to drug development"}]},{"@id":"https://cir.nii.ac.jp/crid/1360283692458685056","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Establishment of Novel Monoclonal Antibody PMab-32 Against Rabbit Podoplanin"}]},{"@id":"https://cir.nii.ac.jp/crid/1360283693320806144","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Physiologic and pathophysiologic roles of interaction between C‐type lectin‐like receptor 2 and podoplanin: partners from in utero to adulthood"}]},{"@id":"https://cir.nii.ac.jp/crid/1360285709458360448","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Development of Monoclonal Antibody LpMab-10 Recognizing Non-glycosylated PLAG1/2 Domain Including Thr34 of Human Podoplanin"}]},{"@id":"https://cir.nii.ac.jp/crid/1360285709458395648","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"ChLpMab-23: Cancer-Specific Human–Mouse Chimeric Anti-Podoplanin Antibody Exhibits Antitumor Activity via Antibody-Dependent Cellular Cytotoxicity"}]},{"@id":"https://cir.nii.ac.jp/crid/1360285709458430464","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Anti-Horse Podoplanin Monoclonal Antibody PMab-219 is Useful for Detecting Lymphatic Endothelial Cells by Immunohistochemical Analysis"}]},{"@id":"https://cir.nii.ac.jp/crid/1360285710465455872","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Antitumor effect of novel anti‐podoplanin antibody NZ‐12 against malignant pleural mesothelioma in an orthotopic xenograft model"}]},{"@id":"https://cir.nii.ac.jp/crid/1360285710467407232","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Therapeutic efficacy evaluation of radioimmunotherapy with <sup>90</sup>Y‐labeled anti‐podoplanin antibody <scp>NZ</scp>‐12 for mesothelioma"}]},{"@id":"https://cir.nii.ac.jp/crid/1360285710529172096","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Prevention of hematogenous metastasis by neutralizing mice and its chimeric anti‐Aggrus/podoplanin antibodies"}]},{"@id":"https://cir.nii.ac.jp/crid/1360286991648854784","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Establishment of a monoclonal antibody PMab-225 against alpaca podoplanin for immunohistochemical analyses"}]},{"@id":"https://cir.nii.ac.jp/crid/1360286994383092992","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"PMab-210: A Monoclonal Antibody Against Pig Podoplanin"}]},{"@id":"https://cir.nii.ac.jp/crid/1360286994383099264","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Establishment of a Monoclonal Antibody PMab-231 for Tiger Podoplanin"}]},{"@id":"https://cir.nii.ac.jp/crid/1360286994383111296","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Epitope Mapping of Antipig Podoplanin Monoclonal Antibody PMab-213"}]},{"@id":"https://cir.nii.ac.jp/crid/1360294643782467072","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Development of an Anti-Elephant Podoplanin Monoclonal Antibody PMab-265 for Flow Cytometry"}]},{"@id":"https://cir.nii.ac.jp/crid/1360565166781728768","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Podoplanin enhances lung cancer cell growth in vivo by inducing platelet aggregation"}]},{"@id":"https://cir.nii.ac.jp/crid/1360565167435394560","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Development of Sensitive Monoclonal Antibody PMab-2 Against Rat Podoplanin"}]},{"@id":"https://cir.nii.ac.jp/crid/1360565167435397632","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Specific Detection of Dog Podoplanin Expressed in Renal Glomerulus by a Novel Monoclonal Antibody PMab-38 in Immunohistochemistry"}]},{"@id":"https://cir.nii.ac.jp/crid/1360565167435401088","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"PMab-52: Specific and Sensitive Monoclonal Antibody Against Cat Podoplanin for Immunohistochemistry"}]},{"@id":"https://cir.nii.ac.jp/crid/1360565169868919552","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Targeting a novel domain in podoplanin for inhibiting platelet-mediated tumor metastasis"}]},{"@id":"https://cir.nii.ac.jp/crid/1360565170866164096","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"A Novel Targeting Therapy of Malignant Mesothelioma Using Anti-Podoplanin Antibody"}]},{"@id":"https://cir.nii.ac.jp/crid/1360567182508461952","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Podoplanin Expression and IDH-Wildtype Status Predict Venous Thromboembolism in Patients with High-Grade Gliomas in the Early Postoperative Period"}]},{"@id":"https://cir.nii.ac.jp/crid/1360567184435067136","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Characterization of Monoclonal Antibody LpMab-7 Recognizing Non-PLAG Domain of Podoplanin"}]},{"@id":"https://cir.nii.ac.jp/crid/1360567184435084416","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Establishment of Mouse Monoclonal Antibody LpMab-13 Against Human Podoplanin"}]},{"@id":"https://cir.nii.ac.jp/crid/1360567184435095040","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Podoplanin Expression in Canine Melanoma"}]},{"@id":"https://cir.nii.ac.jp/crid/1360567184435098624","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Antiglycopeptide Mouse Monoclonal Antibody LpMab-21 Exerts Antitumor Activity Against Human Podoplanin Through Antibody-Dependent Cellular Cytotoxicity and Complement-Dependent Cytotoxicity"}]},{"@id":"https://cir.nii.ac.jp/crid/1360567186299642112","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Expressions of ABCG2, CD133, and Podoplanin in Salivary Adenoid Cystic Carcinoma"}]},{"@id":"https://cir.nii.ac.jp/crid/1360567187542655232","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"LpMab-12 Established by CasMab Technology Specifically Detects Sialylated O-Glycan on Thr52 of Platelet Aggregation-Stimulating Domain of Human Podoplanin"}]},{"@id":"https://cir.nii.ac.jp/crid/1360567188226365952","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"LpMab-23-recognizing cancer-type podoplanin is a novel predictor for a poor prognosis of early stage tongue cancer"}]},{"@id":"https://cir.nii.ac.jp/crid/1360568466625562112","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"PMab-219: A monoclonal antibody for the immunohistochemical analysis of horse podoplanin"}]},{"@id":"https://cir.nii.ac.jp/crid/1360576118759180544","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Epitope Mapping of the Anti-California Sea Lion Podoplanin Monoclonal Antibody PMab-269 Using Alanine-Scanning Mutagenesis and ELISA"}]},{"@id":"https://cir.nii.ac.jp/crid/1360580229832185856","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Targeting Podoplanin for the Treatment of Osteosarcoma"}]},{"@id":"https://cir.nii.ac.jp/crid/1360580230618174848","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Epitope Mapping of an Anti-elephant Podoplanin Monoclonal Antibody (PMab-295) Using Enzyme-Linked Immunosorbent Assay"}]},{"@id":"https://cir.nii.ac.jp/crid/1360580232416435456","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Improved anti‐solid tumor response by humanized anti‐podoplanin chimeric antigen receptor transduced human cytotoxic T cells in an animal model"}]},{"@id":"https://cir.nii.ac.jp/crid/1360846641064101248","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Podoplanin expression profiles characteristic of odontogenic tumor-specific tissue architectures"}]},{"@id":"https://cir.nii.ac.jp/crid/1360846642412107904","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"PMab-44 Detects Bovine Podoplanin in Immunohistochemistry"}]},{"@id":"https://cir.nii.ac.jp/crid/1360846642412113024","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Immunohistochemical Analysis of Inflammatory Rheumatoid Synovial Tissues Using Anti-Human Podoplanin Monoclonal Antibody Panel"}]},{"@id":"https://cir.nii.ac.jp/crid/1360846643109457792","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Chimeric anti‐podoplanin antibody suppresses tumor metastasis through neutralization and antibody‐dependent cellular cytotoxicity"}]},{"@id":"https://cir.nii.ac.jp/crid/1360846643179607808","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"The expression of podoplanin and classic cadherins in the mouse brain"}]},{"@id":"https://cir.nii.ac.jp/crid/1360846643620659200","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"CAR T Cells Targeting Podoplanin Reduce Orthotopic Glioblastomas in Mouse Brains"}]},{"@id":"https://cir.nii.ac.jp/crid/1360848655067371392","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Recombinant anti‐podoplanin (NZ‐1) immunotoxin for the treatment of malignant brain tumors"}]},{"@id":"https://cir.nii.ac.jp/crid/1360848656492477696","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Podoplanin expressing cancer-associated fibroblasts in oral cancer"}]},{"@id":"https://cir.nii.ac.jp/crid/1360848658470893440","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"A critical role of platelet TGF-β release in podoplanin-mediated tumour invasion and metastasis"}]},{"@id":"https://cir.nii.ac.jp/crid/1360848659411777536","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Characterization of Monoclonal Antibody LpMab-3 Recognizing Sialylated Glycopeptide of Podoplanin"}]},{"@id":"https://cir.nii.ac.jp/crid/1360848659411791872","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Critical Epitope of Anti-Rabbit Podoplanin Monoclonal Antibodies for Immunohistochemical Analysis"}]},{"@id":"https://cir.nii.ac.jp/crid/1360848659411802880","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"PMab-38 Recognizes Canine Podoplanin of Squamous Cell Carcinomas"}]},{"@id":"https://cir.nii.ac.jp/crid/1360848659411810816","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Chimeric Anti-Human Podoplanin Antibody NZ-12 of Lambda Light Chain Exerts Higher Antibody-Dependent Cellular Cytotoxicity and Complement-Dependent Cytotoxicity Compared with NZ-8 of Kappa Light Chain"}]},{"@id":"https://cir.nii.ac.jp/crid/1360848659411819648","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Characterization of the Anti-Bovine Podoplanin Monoclonal Antibody PMab-44"}]},{"@id":"https://cir.nii.ac.jp/crid/1360848659411832832","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Expression of Cat Podoplanin in Feline Squamous Cell Carcinomas"}]},{"@id":"https://cir.nii.ac.jp/crid/1360848661650101120","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"A Real-Time Near-Infrared Fluorescence Imaging Method for the Detection of Oral Cancers in Mice Using an Indocyanine Green–Labeled Podoplanin Antibody"}]},{"@id":"https://cir.nii.ac.jp/crid/1360848661702610560","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Cobalt hematoporphyrin inhibits CLEC-2–podoplanin interaction, tumor metastasis, and arterial/venous thrombosis in mice"}]},{"@id":"https://cir.nii.ac.jp/crid/1360848662534285568","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Morphological study of tooth development in podoplanin-deficient mice"}]},{"@id":"https://cir.nii.ac.jp/crid/1360848663203335424","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"A safety study of newly generated anti-podoplanin-neutralizing antibody in cynomolgus monkey (<i>Macaca fascicularis</i>)"}]},{"@id":"https://cir.nii.ac.jp/crid/1360849944336519936","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Epitope Mapping of the Antihorse Podoplanin Monoclonal Antibody PMab-202"}]},{"@id":"https://cir.nii.ac.jp/crid/1360853567459587712","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Novel knock‐in mouse model for the evaluation of the therapeutic efficacy and toxicity of human podoplanin–targeting agents"}]},{"@id":"https://cir.nii.ac.jp/crid/1360853567745856384","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Phase I/II Clinical Trial of the Anti-Podoplanin Monoclonal Antibody Therapy in Dogs with Malignant Melanoma"}]},{"@id":"https://cir.nii.ac.jp/crid/1360857593736580096","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Roles of Podoplanin in Malignant Progression of Tumor"}]},{"@id":"https://cir.nii.ac.jp/crid/1360861294960065920","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Efficacy of cancer-specific anti-podoplanin CAR-T cells and oncolytic herpes virus G47Δ combination therapy against glioblastoma"}]},{"@id":"https://cir.nii.ac.jp/crid/1361131416578986368","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Establishment of a monoclonal antibody PMab-233 for immunohistochemical analysis against Tasmanian devil podoplanin"}]},{"@id":"https://cir.nii.ac.jp/crid/1361131419313233408","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Epitope Mapping of Anti-Tiger Podoplanin Monoclonal Antibody PMab-231"}]},{"@id":"https://cir.nii.ac.jp/crid/1361412894289940224","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"PMab-213: A Monoclonal Antibody for Immunohistochemical Analysis Against Pig Podoplanin"}]},{"@id":"https://cir.nii.ac.jp/crid/1361412894289953152","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Characterization of Anti-Goat Podoplanin Monoclonal Antibody PMab-235 Using Immunohistochemistry Against Goat Tissues"}]},{"@id":"https://cir.nii.ac.jp/crid/1361694366532399360","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"The mouse–canine chimeric anti-dog podoplanin antibody P38B exerts antitumor activity in mouse xenograft models"}]},{"@id":"https://cir.nii.ac.jp/crid/1361975844243377536","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Epitope Mapping of Anti-Bear Podoplanin Monoclonal Antibody PMab-247"}]},{"@id":"https://cir.nii.ac.jp/crid/1363386073374894592","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"New trends in the study of podoplanin as a cell morphological regulator"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001204450139648","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Novel platelet activation receptor CLEC-2  from discovery to prospects"},{"@language":"ja","@value":"新規血小板活性化受容体ＣＬＥＣ－２　　その発見から今後の展望まで"},{"@value":"Novel platelet activation receptor CLEC-2"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001204451337728","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"An overview of the novel platelet activation receptor CLEC-2"},{"@language":"ja","@value":"新規血小板活性化受容体ＣＬＥＣ－２"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001204862333056","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Expression of Podoplanin in the Mouse Tooth Germ and Apical Bud Cells"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282679124422272","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Platelet aggregation in the formation of tumor metastasis"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282679426815872","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"ja","@value":"癌の進展と血小板"},{"@language":"en","@value":"Cancer progression and platelets"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282679427125120","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"ja","@value":"血小板活性化受容体CLEC-2 とその内因性リガンドがポドプラニンであることの同定と，両者の結合の病態生理学的役割の解明"},{"@language":"en","@value":"Identification of the platelet activation receptor CLEC-2, its endogenous ligand podoplanin, and pathophysiological roles of their interaction"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282679838158080","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Distribution of Podoplanin-Expressing Cells in the Mouse Nervous Systems"},{"@value":"Distribution of podoplanin‐expressing cells in the mouse nervous systems"}]},{"@id":"https://cir.nii.ac.jp/crid/1390853113786368640","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Expression of podoplanin in various types of feline tumor tissues"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1007/s00401-006-0063-y"},{"@type":"OPENAIRE","@value":"doi_dedup___::d1c05ba5920f0ad2b3ecc56eaba8abc7"},{"@type":"CROSSREF","@value":"10.1002/cam4.954_references_DOI_OpiclyMf8gTaof1wkcfSUhKReTw"},{"@type":"CROSSREF","@value":"10.1038/srep05924_references_DOI_OpiclyMf8gTaof1wkcfSUhKReTw"},{"@type":"CROSSREF","@value":"10.1111/jth.13604_references_DOI_OpiclyMf8gTaof1wkcfSUhKReTw"},{"@type":"CROSSREF","@value":"10.1089/mab.2015.0022_references_DOI_OpiclyMf8gTaof1wkcfSUhKReTw"},{"@type":"CROSSREF","@value":"10.1111/j.1349-7006.2012.02377.x_references_DOI_OpiclyMf8gTaof1wkcfSUhKReTw"},{"@type":"CROSSREF","@value":"10.3892/ijo.2016.3445_references_DOI_OpiclyMf8gTaof1wkcfSUhKReTw"},{"@type":"CROSSREF","@value":"10.1158/2326-6066.cir-15-0060_references_DOI_OpiclyMf8gTaof1wkcfSUhKReTw"},{"@type":"CROSSREF","@value":"10.1267/ahc.08019_references_DOI_OpiclyMf8gTaof1wkcfSUhKReTw"},{"@type":"CROSSREF","@value":"10.2491/jjsth.20.401_references_DOI_OpiclyMf8gTaof1wkcfSUhKReTw"},{"@type":"CROSSREF","@value":"10.18632/oncotarget.24986_references_DOI_OpiclyMf8gTaof1wkcfSUhKReTw"},{"@type":"CROSSREF","@value":"10.1089/mab.2015.0066_references_DOI_OpiclyMf8gTaof1wkcfSUhKReTw"},{"@type":"CROSSREF","@value":"10.1292/jvms.20-0608_references_DOI_OpiclyMf8gTaof1wkcfSUhKReTw"},{"@type":"CROSSREF","@value":"10.1016/j.bbrc.2020.08.103_references_DOI_OpiclyMf8gTaof1wkcfSUhKReTw"},{"@type":"CROSSREF","@value":"10.3390/cells9091971_references_DOI_OpiclyMf8gTaof1wkcfSUhKReTw"},{"@type":"CROSSREF","@value":"10.1089/mab.2020.0019_references_DOI_OpiclyMf8gTaof1wkcfSUhKReTw"},{"@type":"CROSSREF","@value":"10.1089/mab.2021.0011_references_DOI_OpiclyMf8gTaof1wkcfSUhKReTw"},{"@type":"CROSSREF","@value":"10.1007/s10555-017-9672-2_references_DOI_OpiclyMf8gTaof1wkcfSUhKReTw"},{"@type":"CROSSREF","@value":"10.1111/jth.13590_references_DOI_OpiclyMf8gTaof1wkcfSUhKReTw"},{"@type":"CROSSREF","@value":"10.1089/mab.2015.0041_references_DOI_OpiclyMf8gTaof1wkcfSUhKReTw"},{"@type":"CROSSREF","@value":"10.1089/mab.2016.0022_references_DOI_OpiclyMf8gTaof1wkcfSUhKReTw"},{"@type":"CROSSREF","@value":"10.1089/mab.2017.0014_references_DOI_OpiclyMf8gTaof1wkcfSUhKReTw"},{"@type":"CROSSREF","@value":"10.1111/cas.12985_references_DOI_OpiclyMf8gTaof1wkcfSUhKReTw"},{"@type":"CROSSREF","@value":"10.1111/cas.13979_references_DOI_OpiclyMf8gTaof1wkcfSUhKReTw"},{"@type":"CROSSREF","@value":"10.1111/j.1349-7006.2011.02058.x_references_DOI_OpiclyMf8gTaof1wkcfSUhKReTw"},{"@type":"CROSSREF","@value":"10.18632/oncotarget.5339_references_DOI_OpiclyMf8gTaof1wkcfSUhKReTw"},{"@type":"CROSSREF","@value":"10.1089/mab.2019.0003_references_DOI_OpiclyMf8gTaof1wkcfSUhKReTw"},{"@type":"CROSSREF","@value":"10.1089/mab.2019.0023_references_DOI_OpiclyMf8gTaof1wkcfSUhKReTw"},{"@type":"CROSSREF","@value":"10.1016/j.wneu.2019.05.049_references_DOI_OpiclyMf8gTaof1wkcfSUhKReTw"},{"@type":"CROSSREF","@value":"10.1016/j.prp.2011.12.016_references_DOI_OpiclyMf8gTaof1wkcfSUhKReTw"},{"@type":"CROSSREF","@value":"10.1089/mab.2014.0090_references_DOI_OpiclyMf8gTaof1wkcfSUhKReTw"},{"@type":"CROSSREF","@value":"10.1016/j.bbrep.2019.100631_references_DOI_OpiclyMf8gTaof1wkcfSUhKReTw"},{"@type":"CROSSREF","@value":"10.1089/mab.2021.0015_references_DOI_OpiclyMf8gTaof1wkcfSUhKReTw"},{"@type":"CROSSREF","@value":"10.1016/j.omto.2022.07.006_references_DOI_OpiclyMf8gTaof1wkcfSUhKReTw"},{"@type":"CROSSREF","@value":"10.1002/cam4.1049_references_DOI_OpiclyMf8gTaof1wkcfSUhKReTw"},{"@type":"CROSSREF","@value":"10.1038/s41598-017-04324-1_references_DOI_OpiclyMf8gTaof1wkcfSUhKReTw"},{"@type":"CROSSREF","@value":"10.4049/jimmunol.1300448_references_DOI_OpiclyMf8gTaof1wkcfSUhKReTw"},{"@type":"CROSSREF","@value":"10.1089/mab.2016.0006_references_DOI_OpiclyMf8gTaof1wkcfSUhKReTw"},{"@type":"CROSSREF","@value":"10.1089/mab.2016.0045_references_DOI_OpiclyMf8gTaof1wkcfSUhKReTw"},{"@type":"CROSSREF","@value":"10.1155/2014/132349_references_DOI_OpiclyMf8gTaof1wkcfSUhKReTw"},{"@type":"CROSSREF","@value":"10.1371/journal.pone.0152912_references_DOI_OpiclyMf8gTaof1wkcfSUhKReTw"},{"@type":"CROSSREF","@value":"10.18632/oncotarget.6598_references_DOI_OpiclyMf8gTaof1wkcfSUhKReTw"},{"@type":"CROSSREF","@value":"10.2183/pjab.84.189_references_DOI_OpiclyMf8gTaof1wkcfSUhKReTw"},{"@type":"CROSSREF","@value":"10.18632/oncotarget.26055_references_DOI_OpiclyMf8gTaof1wkcfSUhKReTw"},{"@type":"CROSSREF","@value":"10.2491/jjsth.22.348_references_DOI_OpiclyMf8gTaof1wkcfSUhKReTw"},{"@type":"CROSSREF","@value":"10.1089/mab.2016.0016_references_DOI_OpiclyMf8gTaof1wkcfSUhKReTw"},{"@type":"CROSSREF","@value":"10.1016/j.bbrep.2019.100633_references_DOI_OpiclyMf8gTaof1wkcfSUhKReTw"},{"@type":"CROSSREF","@value":"10.3390/cells10102503_references_DOI_OpiclyMf8gTaof1wkcfSUhKReTw"},{"@type":"CROSSREF","@value":"10.1089/mab.2021.0017_references_DOI_OpiclyMf8gTaof1wkcfSUhKReTw"},{"@type":"CROSSREF","@value":"10.1158/1078-0432.ccr-21-4509_references_DOI_OpiclyMf8gTaof1wkcfSUhKReTw"},{"@type":"CROSSREF","@value":"10.1089/mab.2022.0017_references_DOI_OpiclyMf8gTaof1wkcfSUhKReTw"},{"@type":"CROSSREF","@value":"10.1111/gtc.12972_references_DOI_OpiclyMf8gTaof1wkcfSUhKReTw"},{"@type":"CROSSREF","@value":"10.1111/j.1349-7006.2012.02385.x_references_DOI_OpiclyMf8gTaof1wkcfSUhKReTw"},{"@type":"CROSSREF","@value":"10.1111/j.1469-7580.2012.01484.x_references_DOI_OpiclyMf8gTaof1wkcfSUhKReTw"},{"@type":"CROSSREF","@value":"10.1002/ijc.27919_references_DOI_OpiclyMf8gTaof1wkcfSUhKReTw"},{"@type":"CROSSREF","@value":"10.1007/s13277-014-2450-7_references_DOI_OpiclyMf8gTaof1wkcfSUhKReTw"},{"@type":"CROSSREF","@value":"10.1038/srep42186_references_DOI_OpiclyMf8gTaof1wkcfSUhKReTw"},{"@type":"CROSSREF","@value":"10.1089/mab.2014.0087_references_DOI_OpiclyMf8gTaof1wkcfSUhKReTw"},{"@type":"CROSSREF","@value":"10.1089/mab.2016.0036_references_DOI_OpiclyMf8gTaof1wkcfSUhKReTw"},{"@type":"CROSSREF","@value":"10.1089/mab.2016.0047_references_DOI_OpiclyMf8gTaof1wkcfSUhKReTw"},{"@type":"CROSSREF","@value":"10.1177/1533033818767936_references_DOI_OpiclyMf8gTaof1wkcfSUhKReTw"},{"@type":"CROSSREF","@value":"10.1182/bloodadvances.2018016261_references_DOI_OpiclyMf8gTaof1wkcfSUhKReTw"},{"@type":"CROSSREF","@value":"10.1371/journal.pone.0171912_references_DOI_OpiclyMf8gTaof1wkcfSUhKReTw"},{"@type":"CROSSREF","@value":"10.1089/mab.2019.0001_references_DOI_OpiclyMf8gTaof1wkcfSUhKReTw"},{"@type":"CROSSREF","@value":"10.1016/j.thromres.2012.01.003_references_DOI_OpiclyMf8gTaof1wkcfSUhKReTw"},{"@type":"CROSSREF","@value":"10.2491/jjsth.28.518_references_DOI_OpiclyMf8gTaof1wkcfSUhKReTw"},{"@type":"CROSSREF","@value":"10.1016/j.bbrep.2018.11.005_references_DOI_OpiclyMf8gTaof1wkcfSUhKReTw"},{"@type":"CROSSREF","@value":"10.1111/cas.14891_references_DOI_OpiclyMf8gTaof1wkcfSUhKReTw"},{"@type":"CROSSREF","@value":"10.3390/cells9112529_references_DOI_OpiclyMf8gTaof1wkcfSUhKReTw"},{"@type":"CROSSREF","@value":"10.3390/cells11030575_references_DOI_OpiclyMf8gTaof1wkcfSUhKReTw"},{"@type":"CROSSREF","@value":"10.1089/mab.2019.0012_references_DOI_OpiclyMf8gTaof1wkcfSUhKReTw"},{"@type":"CROSSREF","@value":"10.1089/mab.2015.0078_references_DOI_OpiclyMf8gTaof1wkcfSUhKReTw"},{"@type":"CROSSREF","@value":"10.1089/mab.2018.0044_references_DOI_OpiclyMf8gTaof1wkcfSUhKReTw"},{"@type":"CROSSREF","@value":"10.1089/mab.2015.0018_references_DOI_OpiclyMf8gTaof1wkcfSUhKReTw"},{"@type":"CROSSREF","@value":"10.1089/mab.2017.0027_references_DOI_OpiclyMf8gTaof1wkcfSUhKReTw"},{"@type":"CROSSREF","@value":"10.1089/mab.2018.0048_references_DOI_OpiclyMf8gTaof1wkcfSUhKReTw"},{"@type":"CROSSREF","@value":"10.1089/mab.2019.0022_references_DOI_OpiclyMf8gTaof1wkcfSUhKReTw"},{"@type":"CROSSREF","@value":"10.2491/jjsth.27.3_references_DOI_OpiclyMf8gTaof1wkcfSUhKReTw"},{"@type":"CROSSREF","@value":"10.1089/mab.2019.0025_references_DOI_OpiclyMf8gTaof1wkcfSUhKReTw"},{"@type":"CROSSREF","@value":"10.1089/mab.2017.0047_references_DOI_OpiclyMf8gTaof1wkcfSUhKReTw"},{"@type":"CROSSREF","@value":"10.1016/j.bbrep.2019.01.009_references_DOI_OpiclyMf8gTaof1wkcfSUhKReTw"},{"@type":"CROSSREF","@value":"10.1089/mab.2018.0038_references_DOI_OpiclyMf8gTaof1wkcfSUhKReTw"},{"@type":"CROSSREF","@value":"10.1089/mab.2014.0091_references_DOI_OpiclyMf8gTaof1wkcfSUhKReTw"},{"@type":"CROSSREF","@value":"10.1267/ahc.13035_references_DOI_OpiclyMf8gTaof1wkcfSUhKReTw"},{"@type":"CROSSREF","@value":"10.1089/mab.2017.0016_references_DOI_OpiclyMf8gTaof1wkcfSUhKReTw"},{"@type":"CROSSREF","@value":"10.1089/mab.2016.0040_references_DOI_OpiclyMf8gTaof1wkcfSUhKReTw"},{"@type":"CROSSREF","@value":"10.1089/mab.2017.0046_references_DOI_OpiclyMf8gTaof1wkcfSUhKReTw"},{"@type":"CROSSREF","@value":"10.1016/j.jdsr.2010.01.003_references_DOI_OpiclyMf8gTaof1wkcfSUhKReTw"}]}